An Exploratory Clinical Trial to Assess Safety and Tolerability in Subjects With Dry Eye Disease
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
An Exploratory, Single-Center, Double-Masked, Crossover Clinical Trial to Assess Safety and
Tolerability of 0.25% Reproxalap Ophthalmic Solution Compared to Xiidra® in Subjects with Dry
Eye Disease in a Dry Eye Chamber